<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>8(10)</volume><submitter>Jitsumura M</submitter><funding>Imperial Biomedical Research Centre</funding><funding>Pathway to Portfolio funding</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>The interaction of the gut microbiota with the human host is implicated in the pathogenesis of inflammatory and immunological diseases including ulcerative colitis (UC). Faecal microbiota transplantation (FMT) as a method of restoring gut microbial diversity is of increasing interest as a therapeutic approach in the management of UC. The current literature lacks consensus about the dose of FMT, route of administration and duration of response.&lt;h4>Methods and analysis&lt;/h4>This single-blinded randomised trial will explore the feasibility of FMT in 30 treatment-naïve patients with histologically confirmed distal UC limited to the recto-sigmoid region (up to 40 cm from the anal verge). This study aims to estimate the magnitude of treatment response to FMT under controlled co</pubmed_abstract><journal>BMJ open</journal><pagination>e021987</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6196852</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Protocol for faecal microbiota transplantation in ulcerative colitis (FMTUC): a randomised feasibility study.</pubmed_title><pmcid>PMC6196852</pmcid><pubmed_authors>Hitchings MD</pubmed_authors><pubmed_authors>Islam S</pubmed_authors><pubmed_authors>Williams JG</pubmed_authors><pubmed_authors>Cunningham AL</pubmed_authors><pubmed_authors>Wilkinson TS</pubmed_authors><pubmed_authors>Harris DA</pubmed_authors><pubmed_authors>Kinross J</pubmed_authors><pubmed_authors>Jitsumura M</pubmed_authors><pubmed_authors>Row PE</pubmed_authors><pubmed_authors>Jenkins GJ</pubmed_authors><pubmed_authors>Riddell AD</pubmed_authors><pubmed_authors>Davies AP</pubmed_authors></additional><is_claimable>false</is_claimable><name>Protocol for faecal microbiota transplantation in ulcerative colitis (FMTUC): a randomised feasibility study.</name><description>&lt;h4>Background&lt;/h4>The interaction of the gut microbiota with the human host is implicated in the pathogenesis of inflammatory and immunological diseases including ulcerative colitis (UC). Faecal microbiota transplantation (FMT) as a method of restoring gut microbial diversity is of increasing interest as a therapeutic approach in the management of UC. The current literature lacks consensus about the dose of FMT, route of administration and duration of response.&lt;h4>Methods and analysis&lt;/h4>This single-blinded randomised trial will explore the feasibility of FMT in 30 treatment-naïve patients with histologically confirmed distal UC limited to the recto-sigmoid region (up to 40 cm from the anal verge). This study aims to estimate the magnitude of treatment response to FMT under controlled co</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Oct</publication><modification>2026-06-06T20:37:35.692Z</modification><creation>2019-03-27T00:04:10Z</creation></dates><accession>S-EPMC6196852</accession><cross_references><pubmed>30341117</pubmed><doi>10.1136/bmjopen-2018-021987</doi></cross_references></HashMap>